Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126338651 | 12633865 | 1 | I | 20160303 | 0 | 20160808 | 20160808 | DIR | 93.00 | YR | M | N | 140.00000 | LBS | 0 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126338651 | 12633865 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | Y | D | 0 | |||||||||
| 126338651 | 12633865 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | 0 | ||||||||||||
| 126338651 | 12633865 | 5 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 126338651 | 12633865 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 126338651 | 12633865 | 9 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 0 | ||||||||||||
| 126338651 | 12633865 | 11 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 126338651 | 12633865 | 13 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126338651 | 12633865 | 1 | Urinary tract infection |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126338651 | 12633865 | Dysstasia | |
| 126338651 | 12633865 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |